159 related articles for article (PubMed ID: 37396313)
1. LOXL1-AS1 Drives the Progression of Gastric Cancer via Regulating miR-142-5p/PIK3CA Axis [Retraction].
Onco Targets Ther; 2023; 16():473-474. PubMed ID: 37396313
[TBL] [Abstract][Full Text] [Related]
2. LOXL1-AS1 Drives The Progression Of Gastric Cancer Via Regulating miR-142-5p/PIK3CA Axis.
Li M; Cai O; Tan S
Onco Targets Ther; 2019; 12():11345-11357. PubMed ID: 31908498
[TBL] [Abstract][Full Text] [Related]
3. Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis.
Guo T; Peng S; Liu D; Li Y
Biochem Genet; 2022 Dec; 60(6):2416-2433. PubMed ID: 35441953
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression.
Liu Y; Guo C; Li F; Wu L
Cell Biochem Funct; 2020 Jan; 38(1):58-65. PubMed ID: 31732974
[TBL] [Abstract][Full Text] [Related]
5. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction].
Onco Targets Ther; 2022; 15():681-682. PubMed ID: 35733651
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p/USF1 pathway.
Sun Q; Li J; Li F; Li H; Bei S; Zhang X; Feng L
Cell Prolif; 2019 Nov; 52(6):e12687. PubMed ID: 31468594
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590-5p mediated KLF6/VEGF signaling pathway.
Cheng X; Liu Z; Zhang H; Lian Y
Cell Cycle; 2021 Sep; 20(17):1663-1680. PubMed ID: 34334119
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
Bai T; Liu Y; Li B
IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
[TBL] [Abstract][Full Text] [Related]
9. Long Non-coding RNA LOXL1-AS1 Drives Breast Cancer Invasion and Metastasis by Antagonizing miR-708-5p Expression and Activity.
Dong HT; Liu Q; Zhao T; Yao F; Xu Y; Chen B; Wu Y; Zheng X; Jin F; Li J; Xing P
Mol Ther Nucleic Acids; 2020 Mar; 19():696-705. PubMed ID: 31945728
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
[TBL] [Abstract][Full Text] [Related]
11. LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis.
Yi B; Li H; Cai H; Lou X; Yu M; Li Z
J Cell Mol Med; 2022 Jan; 26(2):475-490. PubMed ID: 34890108
[TBL] [Abstract][Full Text] [Related]
12. LINC01436 Promotes the Progression of Gastric Cancer via Regulating miR-513a-5p/APE1 Axis [Retraction].
Onco Targets Ther; 2022; 15():701-702. PubMed ID: 35769126
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA LOXL1-AS1 Enhances Colorectal Cancer Proliferation, Migration and Invasion Through miR-708-5p/CD44-EGFR Axis.
Wu X; Cui F; Chen Y; Zhu Y; Liu F
Onco Targets Ther; 2020; 13():7615-7627. PubMed ID: 32821123
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LOXL1-AS1 controls osteogenic and adipocytic differentiation of bone marrow mesenchymal stem cells in postmenopausal osteoporosis through regulating the miR-196a-5p/Hmga2 axis.
Zhang L; Xie H; Li S
J Bone Miner Metab; 2020 Nov; 38(6):794-805. PubMed ID: 32651705
[TBL] [Abstract][Full Text] [Related]
15. The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
Zhang P; Zhao F; Jia K; Liu X
Bioengineered; 2022 Feb; 13(2):2567-2584. PubMed ID: 35015607
[TBL] [Abstract][Full Text] [Related]
16. LOXL1-AS1 contributes to the proliferation and migration of laryngocarcinoma cells through miR-589-5p/TRAF6 axis.
He G; Yao W; Li L; Wu Y; Feng G; Chen L
Cancer Cell Int; 2020; 20():504. PubMed ID: 33061856
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
Yang X; Xing G; Liu S; Li B; He Y; Wang F
Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LOXL1-AS1 is transcriptionally activated by JUND and contributes to osteoarthritis progression via targeting the miR-423-5p/KDM5C axis.
Chen K; Fang H; Xu N
Life Sci; 2020 Oct; 258():118095. PubMed ID: 32679142
[TBL] [Abstract][Full Text] [Related]
19. Targeted-regulating of miR-515-5p by LncRNA LOXL1-AS1 on the proliferation and migration of trophoblast cells.
Zhang L; Wan Q; Zhou H
Exp Mol Pathol; 2021 Feb; 118():104588. PubMed ID: 33278425
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA HAND2-AS1 Inhibits Growth and Migration of Gastric Cancer Cells Through Regulating the miR-590-3p/KCNT2 Axis [Retraction].
Onco Targets Ther; 2021; 14():4997-4998. PubMed ID: 34675541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
